ストックスクリーナーアプリを入手
0.6486
1.82%
0.0116
前日終値:
$0.637
開ける：
$0.637
24時間の取引高:
746.62K
Relative Volume:
1.96
時価総額：
$25.74M
収益：
-
当期純損益:
$-17.78M
株価収益率:
-1.181
EPS:
-0.5492
ネットキャッシュフロー:
$-10.52M
1週間 パフォーマンス:
-4.15%
1か月 パフォーマンス:
+7.99%
6か月 パフォーマンス:
-59.71%
1年 パフォーマンス:
-87.11%
1日の値動き範囲:
$0.6031
$0.658
1週間の範囲:
$0.5801
$0.7198
52週間の値動き範囲:
$0.5801
$5.035
Fibrobiologics Inc Stock (FBLG) Company Profile
FBLG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.6486 | 26.37M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-12 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-24 | 開始されました | Maxim Group | Buy |
Fibrobiologics Inc (FBLG) 最新ニュース
FibroBiologics Inc. Stock Analysis and ForecastAchieve consistent profits with proven strategies - jammulinksnews.com
Should I hold or sell FibroBiologics Inc. stock in 2025Achieve breakthrough financial results today - jammulinksnews.com
What makes FibroBiologics Inc. stock price move sharplyFree Stock Index Interpretation - jammulinksnews.com
What are the technical indicators suggesting about FibroBiologics Inc.Dynamic investment growth - jammulinksnews.com
Is FibroBiologics Inc. a growth stock or a value stockHigh-yield investments - jammulinksnews.com
What institutional investors are buying FibroBiologics Inc. stockCapitalize on emerging growth stocks - jammulinksnews.com
How strong is FibroBiologics Inc. company’s balance sheetBuild a diversified portfolio for maximum returns - jammulinksnews.com
Has FibroBiologics Inc. found a price floorFree Portfolio Diversification Stock Ideas - Newser
Multi asset correlation models including FibroBiologics Inc.Weekly Signal Report with Trend Summary - Newser
Published on: 2025-08-01 21:09:45 - Newser
How does FibroBiologics Inc. compare to its industry peersStock Market Ideas With Proven Results - jammulinksnews.com
Fibrobiologics, Inc. shares fall 1.41% intraday after reporting Q2 2025 earnings and closing a $5 million financing tranche. - AInvest
Key metrics from FibroBiologics Inc.’s quarterly dataFree Secure Return Focused Investment Plan - Newser
Using portfolio simulators with FibroBiologics Inc. includedLong-Term Investment Strategy Impact Analysis - Newser
FibroBiologics’ (FBLG) Buy Rating Reiterated at D. Boral Capital - Defense World
Published on: 2025-08-01 00:21:42 - Newser
Analyzing drawdowns of FibroBiologics Inc. with statistical toolsTechnical Setup and Return Forecast Engine - Newser
FibroBiologics Announces 1H Results: Net Loss of $9.6mln, Cash at $8.8mln - AInvest
FibroBiologics Q2 2025 Earnings Release: Negative Earnings Amid Industry-Wide Skepticism - AInvest
FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
FibroBiologics Raises $5M, Fast-Tracks Revolutionary Fibroblast Therapy for Diabetic Foot Ulcers - Stock Titan
What are analysts’ price targets for FibroBiologics Inc. in the next 12 monthsMarket Forecast Review For 2025 - jammulinksnews.com
Building trade automation scripts for FibroBiologics Inc.Free Conservative Long Term Growth Plans - Newser
How FibroBiologics Inc. stock performs during market volatilityHigh Return Strategy with Low Risk - Newser
Using data filters to optimize entry into FibroBiologics Inc.AI Screener for Daily Stock Forecast - Newser
Investors Hope for Bounce in FibroBiologics Inc. After SelloffStep-by-Step Stock Investment Guide Gains Popularity - beatles.ru
Published on: 2025-07-30 00:29:07 - metal.it
Heatmap Data Shows High Activity in FibroBiologics Inc. SectorHigh Win Rate Trading Opportunities Detected - metal.it
FibroBiologics: D. Boral Capital maintains Buy, raises PT to $16 from $15. - AInvest
Price Reversal in FibroBiologics Inc. Traders Watch CloselyFast Return Equity Trade Forecast Points to Small Caps - metal.it
Strategies to average down on FibroBiologics Inc.Sector Rotation and Stock Opportunity Analysis - Newser
What catalysts could drive FibroBiologics Inc. stock higher in 2025Free Stock Growth Plan For Smart Trading - jammulinksnews.com
Fibrobiologics, Inc. shares rise 2.13% after-hours after filing a patent for generating multipotent cells from fibroblasts. - AInvest
FibroBiologics files patent application on generating multipotent cells - TipRanks
Fibrobiologics, Inc. shares fall 2.66% intraday after filing a patent application for generating multipotent cells from fibroblasts. - AInvest
Orthopediatrics Corp. shares fall 1.28% intraday as FibroBiologics files patent for multipotent cell generation. - AInvest
FibroBiologics files patent for multipotent cell generation method - Investing.com Australia
FibroBiologics files patent for multipotent cell generation method By Investing.com - Investing.com India
FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications - GlobeNewswire
Patent Filing: FibroBiologics Unveils Revolutionary Method to Generate Therapeutic Cells from Donor Tissue - Stock Titan
Is it the right time to buy FibroBiologics Inc. stockExpert Picks Watchlist For 2025 - jammulinksnews.com
What are the latest earnings results for FibroBiologics Inc.Skyrocketing returns - jammulinksnews.com
Fibrobiologics Inc (FBLG) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):